Physician Profile
Grace A. Makhlouf, M.D. is a specialist based in Sugar Land, TX. Medicare claims data shows Grace provided 176,351 services to 2,501 patients. The services billed most often include injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered), injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered), and injection, golimumab, 1 mg, for intravenous use.
Summarised automatically from public NPI registry and CMS Medicare data. Not written or reviewed by this provider. Claim this profile to replace it — free, and no identity document with a practice or institutional email.
License numbers are what the provider reported to NPPES when the NPI was issued or updated. NPPES does not verify licensure; confirm current standing with the state licensing board.
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
1429 HIGHWAY 6 SOUTH STE 103
Sugar Land, TX 77478
176,351 services · 2,501 patients · 23 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Insertion of needle into vein for collection of blood sample | Procedure | 36415 |
801 | More often than most peers in Specialist |
| Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | Imaging | 77085 |
18 | Too few peers to compare |
| Administration of chemotherapy into vein, 1 hour or less | Treatment | 96413 |
920 | More than most peers in Specialist |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Treatment | 96401 |
479 | More often than most peers in Specialist |
| Administration of chemotherapy into vein, each additional hour | Treatment | 96415 |
56 | Less often than most peers in Specialist |
| Influenza vaccine split virus, preservative free | Treatment | 90662 |
25 | As often as other peers in Specialist |
| Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Drug given | J0717 |
95,600 | More often than most peers in Specialist |
| Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Drug given | J0129 |
60,450 | More than most peers in Specialist |
| Injection, golimumab, 1 mg, for intravenous use | Drug given | J1602 |
10,300 | Less often than most peers in Specialist |
| Injection, infliximab, excludes biosimilar, 10 mg | Drug given | J1745 |
3,060 | As often as other peers in Specialist |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Grace A. Makhlouf is a specialist in Sugar Land, TX. That is the designation recorded for this NPI in the federal registry.
NPI registry
Grace A. Makhlouf is listed at 1429 Highway 6 South Ste 103, Sugar Land, TX 77478. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (713) 273-5881. Guide.md cannot book appointments or pass on messages — please call the office directly.
NPI registry
Grace A. Makhlouf's National Provider Identifier is 1124073655. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Grace A. Makhlouf attended Other, graduating in 1992. This comes from the CMS National Downloadable File.
CMS public data
Grace A. Makhlouf has 34 years experience. Calculated from a graduation year of 1992, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, Grace A. Makhlouf performs procedures including insertion of needle into vein for collection of blood sample; reads or performs imaging such as dxa bone density measurement of hip, pelvis, spine including spine fracture assessment; provides treatments such as administration of chemotherapy into vein, 1 hour or less and administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by Grace A. Makhlouf. If this is you, claiming it is free.
Guide.md
Provider data sourced from the NPPES NPI Registry and CMS public datasets. Information is provided for reference and is not medical advice.